The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis

S Bathina, R Armamento-Villareal - Frontiers in endocrinology, 2023 - frontiersin.org
Fractures associated with Type2 diabetes (T2DM) are major public health concerns in an
increasingly obese and aging population. Patients with obesity or T2DM have normal or …

Cross-talk between Wnt signaling and Src tyrosine kinase

JK Min, HS Park, YB Lee, JG Kim, JI Kim, JB Park - Biomedicines, 2022 - mdpi.com
Src, a non-receptor tyrosine kinase, was first discovered as a prototype oncogene and has
been shown to critical for cancer progression for a variety of tissues. Src activity is regulated …

The Critical Role of The Piezo1/β‐catenin/ATF4 Axis on The Stemness of Gli1+ BMSCs During Simulated Microgravity‐Induced Bone Loss

Y Hu, H Tian, W Chen, Y Liu, Y Cao, H Pei… - Advanced …, 2023 - Wiley Online Library
Disuse osteoporosis is characterized by decreased bone mass caused by abnormal
mechanical stimulation of bone. Piezo1 is a major mechanosensitive ion channel in bone …

Advances in the study of traditional Chinese medicine affecting bone metabolism through modulation of oxidative stress

J Li, H Cao, X Zhou, J Guo, C Zheng - Frontiers in Pharmacology, 2023 - frontiersin.org
Bone metabolic homeostasis is dependent on coupled bone formation dominated by
osteoblasts and bone resorption dominated by osteoclasts, which is a process of dynamic …

Comprehensive analysis of epigenetics mechanisms in osteoporosis

Y Chen, Y Sun, X Xue, H Ma - Frontiers in Genetics, 2023 - frontiersin.org
Epigenetic modification pertains to the alteration of genetic-expression, which could be
transferred to the next generations, without any alteration in the fundamental DNA …

Research Progress on the Mechanism of the SFRP-Mediated Wnt Signalling Pathway Involved in Bone Metabolism in Osteoporosis

F An, J Song, W Chang, J Zhang, P Gao, Y Wang… - Molecular …, 2024 - Springer
Osteoporosis (OP) is a metabolic bone disease linked to an elevated fracture risk, primarily
stemming from disruptions in bone metabolism. Present clinical treatments for OP merely …

[PDF][PDF] 老鹳草素抗骨质疏松症机制的研究进展

芮琛, 赵怡凡, 刘天鹏, 赵少川, 郭雅雯, 杨锋 - 中国医药导报, 2023 - yiyaodaobao.com.cn
老Ç 草素(Ge) 能够抑制破骨细胞(OC) 的增殖分化和促进成骨细胞(OB) 的增殖分化,
促进骨髓间充质干细胞向成骨分化, 本文通过检索近年来维普, 中国知网, PubMed …

[HTML][HTML] Roles and mechanisms of optineurin in bone metabolism

J Jin, R Huang, Y Chang, X Yi - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Optineurin (OPTN) is a widely expressed multifunctional articulatory protein that participates
in cellular or mitochondrial autophagy, vesicular transport, and endoplasmic reticulum (ER) …

Decreasing miR-433-3p activity in the osteoblast lineage blunts glucocorticoid-mediated bone loss

P Thakore, S Karki, HC Hrdlicka, J Garcia-Munoz… - …, 2025 - academic.oup.com
Glucocorticoid excess causes bone loss due to decreased bone formation and increased
bone resorption; miR-433-3p is a miRNA that negatively regulates bone formation in male …

LDL receptor-related protein 5 rs648438 polymorphism is associated with the risk of skeletal fluorosis

M Zhang, H Xu, Q Lou, F Yin, N Guo, L Wu… - International Journal …, 2024 - Taylor & Francis
To investigate the potential association between LRP5 rs648438 polymorphism and the risk
of skeletal fluorosis (SF) was evaluated in a cross-sectional case–control study conducted in …